Cargando…

Maximum surgical blood order schedule for flap reconstruction in oral and maxillofacial cancer patients

BACKGROUND: We established a MSBOS for flap reconstruction in oral and maxillofacial cancer patients. METHOD: We enrolled 2080 cases of oral and maxillofacial flap reconstruction from January 1, 2010 to December 31, 2021. Patient data were collected, including age, sex, BMI, preoperative Hb levels,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yili, Li, Xueer, Wang, Yuepeng, Chen, Yanhong, Li, Dandan, Jiang, Qiming, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341105/
https://www.ncbi.nlm.nih.gov/pubmed/35915482
http://dx.doi.org/10.1186/s12903-022-02357-1
_version_ 1784760542687133696
author Zhao, Yili
Li, Xueer
Wang, Yuepeng
Chen, Yanhong
Li, Dandan
Jiang, Qiming
Wang, Yan
author_facet Zhao, Yili
Li, Xueer
Wang, Yuepeng
Chen, Yanhong
Li, Dandan
Jiang, Qiming
Wang, Yan
author_sort Zhao, Yili
collection PubMed
description BACKGROUND: We established a MSBOS for flap reconstruction in oral and maxillofacial cancer patients. METHOD: We enrolled 2080 cases of oral and maxillofacial flap reconstruction from January 1, 2010 to December 31, 2021. Patient data were collected, including age, sex, BMI, preoperative Hb levels, ASA grade, T stage, flap type, tumor location, and bone flap. Scoring criteria were established based on a multivariate model of independent risk variables and their odds ratios. Two flap-type groups were divided into low-risk, intermediate-risk and high-risk groups by the scoring criteria, and analyzed using univariate and multivariate logistic regression. Perioperative transfusion analysis identified independent risk factors at various Hb levels. The cumulative percentage of patients requiring perioperative blood transfusion for each surgical procedure was calculated to establish the MSBOS. RESULTS: (1) Regression analysis showed that BMI, tumor T staging, ASA grade, preoperative Hb level (male: Hb < 130 g/L, female: Hb < 120 g/L), and bone flap were independent risk factors for perioperative blood transfusion. (2) Regression analysis showed that independent risk factors for perioperative transfusion included the following: BMI, tumor T3–T4 stage, ASA III, IV grade, and free flap/pediculated flap/bone flap in patients with different Hb levels; T3–T4 stage, ASA grade III–IV in mildly anemic patients; and ASA grade III–IV in moderately anemic patients. (3) A MSBOS was established for flap reconstruction in head and neck cancer patients. CONCLUSION: A MSBOS for head and neck cancer procedures was reduced by approximately 30% perioperative blood preparation while ensuring that clinical blood use standards were met. It help optimize blood inventory, and save blood resources.
format Online
Article
Text
id pubmed-9341105
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93411052022-08-02 Maximum surgical blood order schedule for flap reconstruction in oral and maxillofacial cancer patients Zhao, Yili Li, Xueer Wang, Yuepeng Chen, Yanhong Li, Dandan Jiang, Qiming Wang, Yan BMC Oral Health Research BACKGROUND: We established a MSBOS for flap reconstruction in oral and maxillofacial cancer patients. METHOD: We enrolled 2080 cases of oral and maxillofacial flap reconstruction from January 1, 2010 to December 31, 2021. Patient data were collected, including age, sex, BMI, preoperative Hb levels, ASA grade, T stage, flap type, tumor location, and bone flap. Scoring criteria were established based on a multivariate model of independent risk variables and their odds ratios. Two flap-type groups were divided into low-risk, intermediate-risk and high-risk groups by the scoring criteria, and analyzed using univariate and multivariate logistic regression. Perioperative transfusion analysis identified independent risk factors at various Hb levels. The cumulative percentage of patients requiring perioperative blood transfusion for each surgical procedure was calculated to establish the MSBOS. RESULTS: (1) Regression analysis showed that BMI, tumor T staging, ASA grade, preoperative Hb level (male: Hb < 130 g/L, female: Hb < 120 g/L), and bone flap were independent risk factors for perioperative blood transfusion. (2) Regression analysis showed that independent risk factors for perioperative transfusion included the following: BMI, tumor T3–T4 stage, ASA III, IV grade, and free flap/pediculated flap/bone flap in patients with different Hb levels; T3–T4 stage, ASA grade III–IV in mildly anemic patients; and ASA grade III–IV in moderately anemic patients. (3) A MSBOS was established for flap reconstruction in head and neck cancer patients. CONCLUSION: A MSBOS for head and neck cancer procedures was reduced by approximately 30% perioperative blood preparation while ensuring that clinical blood use standards were met. It help optimize blood inventory, and save blood resources. BioMed Central 2022-08-01 /pmc/articles/PMC9341105/ /pubmed/35915482 http://dx.doi.org/10.1186/s12903-022-02357-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhao, Yili
Li, Xueer
Wang, Yuepeng
Chen, Yanhong
Li, Dandan
Jiang, Qiming
Wang, Yan
Maximum surgical blood order schedule for flap reconstruction in oral and maxillofacial cancer patients
title Maximum surgical blood order schedule for flap reconstruction in oral and maxillofacial cancer patients
title_full Maximum surgical blood order schedule for flap reconstruction in oral and maxillofacial cancer patients
title_fullStr Maximum surgical blood order schedule for flap reconstruction in oral and maxillofacial cancer patients
title_full_unstemmed Maximum surgical blood order schedule for flap reconstruction in oral and maxillofacial cancer patients
title_short Maximum surgical blood order schedule for flap reconstruction in oral and maxillofacial cancer patients
title_sort maximum surgical blood order schedule for flap reconstruction in oral and maxillofacial cancer patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341105/
https://www.ncbi.nlm.nih.gov/pubmed/35915482
http://dx.doi.org/10.1186/s12903-022-02357-1
work_keys_str_mv AT zhaoyili maximumsurgicalbloodorderscheduleforflapreconstructioninoralandmaxillofacialcancerpatients
AT lixueer maximumsurgicalbloodorderscheduleforflapreconstructioninoralandmaxillofacialcancerpatients
AT wangyuepeng maximumsurgicalbloodorderscheduleforflapreconstructioninoralandmaxillofacialcancerpatients
AT chenyanhong maximumsurgicalbloodorderscheduleforflapreconstructioninoralandmaxillofacialcancerpatients
AT lidandan maximumsurgicalbloodorderscheduleforflapreconstructioninoralandmaxillofacialcancerpatients
AT jiangqiming maximumsurgicalbloodorderscheduleforflapreconstructioninoralandmaxillofacialcancerpatients
AT wangyan maximumsurgicalbloodorderscheduleforflapreconstructioninoralandmaxillofacialcancerpatients